29
Oct
2026
Featuring Megha Miller, MSN, FNP-C & Cody Miller, MBA | Komal Aesthetics | Portland, OR
Just over a year ago, Komal Aesthetics was a solo, NP-owned practice operating out of a salon suite in the suburbs of Portland, Oregon. Today, it is a fast-growing boutique med spa generating six figures in monthly revenue, with approximately 80% driven by energy-based devices (EBD).
At the center of that growth is a deliberate strategy: invest in technology that delivers clinical results, scalable margins, and long-term differentiation.
“We started as a very small, word-of-mouth practice,” says Megha Miller, MSN, FNP-C, founder and lead provider at Komal Aesthetics. “But every patient who walked in had skin concerns. Injectables alone weren’t enough.”
In November 2024, while still operating out of a salon suite, Megha made her first major technology investment, bringing Ultra and Mosaic into the practice.
The impact was immediate. Within the first month, Komal Aesthetics generated approximately $70,000 in laser revenue, giving Megha the confidence (and the capital) to open a three-treatment-room clinic.
“That decision changed everything,” she says. “It was scary, but it was the best decision I’ve made for my practice.”
Just two months later, Megha recognized what the data was showing: energy-based treatments delivered significantly better margins than injectables. That insight led to additional investments in RFMN and Clarity II, bringing the practice to five devices in rapid succession.
Today, Komal Aesthetics operates with a diversified portfolio of technologies that allows the team to treat virtually every skin concern, often in combination.
“Our focus is tailored treatment plans,” Megha explains. “We use complementary technologies because that’s how you get the best results. We don’t force one device. We choose what the skin actually needs.”
Popular complementary treatments include:
Patients undergo a facial scan at consultation, allowing Megha to build customized, education-driven treatment plans, an approach that naturally drives acceptance.
“I love educating patients,” she says. “When they understand the why, the treatment sells itself.”
In September, Komal Aesthetics became the first practice in Oregon to launch XERF, its sixth major device investment in under a year. Despite initial nerves, the launch exceeded expectations.
With just 22 attendees, the XERF launch event generated approximately $45,000 in sales. Since launching in September, the practice has driven around $90,000 in XERF revenue, with consistent demand month over month.
“We were pre-selling before the device even arrived,” says Cody Miller, MBA, who oversees finance and operations. “I worried about a post-launch drop-off, but that hasn’t happened. XERF has been steady.”
XERF has also driven new patient acquisition, with patients seeking out Komal Aesthetics specifically because the practice offers the technology.
“We’re seeing younger patients finding us on TikTok and Instagram, and older patients who need more education,” Megha adds. “XERF speaks to both groups.”
Megha and Cody operate as a true power couple, the perfect blend of yin and yang. Megha leads medical and clinical strategy, while Cody works behind the scenes optimizing operations, processes, and technology to ensure the business scales efficiently.
While Megha drives clinical confidence, Cody manages the financial lens, tracking depreciation, cash flow, and margins across all devices.
“I was highly skeptical at first,” Cody admits. “We took on real risk. I look at monthly depreciation, margins, and cash flow, because at the end of the day, cash flow is king.”
That discipline paid off.
“After one year, we could pay off every device in cash and still have money left over,” he says. “Some devices are outperforming projections. Collectively, the portfolio has been incredibly strong financially.”
XERF, in particular, stands out.
“Ultra is our bread and butter,” Cody explains. “But XERF is a bigger-ticket treatment. I expect XERF to surpass Ultra in total revenue over time.”
Komal Aesthetics runs lean, intentional marketing, primarily:
“One or two laser patients cover our entire monthly marketing spend,” Cody says. “Laser campaigns hit harder, and the margins make sense.”
Each device launch party consistently generated $20,000–$60,000 per event, drawing a mix of existing and new patients.
In a local market where many competitors rely heavily on filler and toxin, Komal Aesthetics stands apart.
“Devices are easier to scale,” Cody explains. “They’re delegatable, trainable, and don’t rely on a single injector. That’s huge for growth.”
Megha credits Cynosure Lutronic not just for the technology, but for the partnership.
“Our rep and PDC have been incredible,” she says. “They didn’t stop at install. They helped train staff, refine protocols, and even guide us on cross-selling and positioning.”
As Komal Aesthetics enters its second full year in a larger space, the practice continues to grow, both in revenue and reputation.
“We have the right people, the right technology, and most importantly, the trust of our patients,” Megha says. “I had to believe in myself, and I’m so grateful I did.”
For Komal Aesthetics, energy-based devices didn’t just add services. They transformed the trajectory of the practice.
Laser-led growth isn’t just possible. It’s scalable, profitable, and sustainable, even for small, boutique practices outside major metro markets.
Intended for distribution in the United States and Canada only.
USA: The XERF device is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. All instances of the term “skin tightening” are used to describe tightening effects that occur via soft tissue coagulation.
Canada: The XERF™ system is intended as a non-invasive dermatological aesthetic treatment device with indications for facial lines and wrinkles, lift the eyebrow, and facial and neck laxity.
Cynosure, LLC and Lutronic Aesthetic, Inc. do not diagnose or treat medical conditions, prescribe treatment protocols, provide medical advice, or otherwise practice medicine. Patients should consult with a qualified healthcare professional for diagnosis and proper treatment protocols/parameters to determine if treatment with any product is right for them. Qualified healthcare professionals are responsible for diagnosis and treatment protocols using products.
©2025 CYNOSURE LUTRONIC, INC. All Rights Reserved. XERF and Lutronic are registered trademarks of Lutronic Corporation. Cynosure is a registered trademark of Cynosure, LLC.
Revenue and profitability outcomes for med spas vary based on numerous factors, including but not limited to practice size, patient mix, pricing, utilization, staffing, and market conditions. Any revenue or financial information presented is for illustrative purposes only and should not be considered a guarantee or projection of actual results.
Ready to find your beautiful? Get started by locating a Cynosure Lutronic provider near you.